Delivery Order 75H71220D00007-75H71220F28001
Award Date
9/2/20
Potential Completion Date
8/31/21
Potential Value
$69K
Federal Agency
Indian Health Service
Awardee
Biofire Diagnostics LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Phoenix, AZ 85016, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $286,617.93 firm fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services Indian Health Service to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for cost per test and supplies. The contract has a period of performance through July 31, 2023 and does not have a set-aside designation. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contracts and task orders to...
This is a firm fixed-price purchase order awarded by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services, to Biofire Diagnostics LLC for the provision of a BIOFIRE ANALYZER, KITS AND PANELS, and UNO SERVICE UNIT to support COVID-19 response efforts. The award, valued at $57,100.00, has an ultimate completion date of October 31, 2021. Biofire Diagnostics LLC is a foreign-owned, for-profit organization that specializes in syndromic infectious...
This contract was awarded by the Department of Health and Human Services (HHS) Indian Health Service (IHS) to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for the provision of laboratory bio-fire supplies. The contract is a firm-fixed price purchase order with a potential value of $2,364,710.15 and a performance period ending on March 14, 2024. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contract awards to...
This federal contract award was made by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The contract, valued at $92,180.60, is for the purchase of Biofire diagnostic products and services, including molecular diagnostic testing services, COVID-19 testing reagents and equipment, and maintenance services for Biofire systems. The...
This is a $2,474,747.75 fixed-price purchase order awarded by the Defense Health Agency to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for the provision of testing kits and panels for Bloodstream Infections, COVID-19, Meningitis/Encephalitis, and other infectious diseases. The contract has an ultimate completion date of April 29, 2026 and does not utilize a set-aside designation. Biofire Diagnostics LLC is an experienced federal contractor, holding several indefinite...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services Indian Health Service to Biofire Diagnostics LLC, a foreign-owned for-profit organization. The $149,038.88 contract is for a lab lease agreement and supplies, with a completion date of October 31, 2018. Biofire Diagnostics LLC is a biotech company that specializes in syndromic infectious disease testing and has received numerous federal contracts to provide a variety of related goods and services,...
This federal contract award was made by the Department of Health and Human Services Indian Health Service to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The $218,091.46 Firm Fixed Price purchase order is for CCHCF-FY2019 CH-LAB PRIORITY A CPT (BIOFIRE- IHS5419217) services to be delivered by December 31, 2019. The contract does not have a set-aside designation. Biofire Diagnostics LLC holds several indefinite...
The Defense Health Agency awarded a firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide molecular diagnostic testing kits. The $242,760 contract has a completion date of September 30, 2022 and was not set aside for any particular business type. Biofire Diagnostics is a leader in syndromic infectious disease testing and has held numerous federal contracts to supply a range of testing products and services, including to the...
This is a sole source contract awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for cost per test and supplies. The contract has a ceiling value of $98,811.48 and was awarded on December 29, 2020 as a firm fixed price purchase order. The contract is for the lease of one FLM2-SRV-0001 instrument and associated supplies for the laboratory department at the Chinle...
This federal contract award, valued at $267,240.00, was issued by the Indian Health Service (IHS) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company. The contract is for the provision of support services, parts, maintenance, phone support, on-site services, and software updates for Biofire's infectious disease testing products and services. The contract is a firm fixed-price purchase order with a period of performance through September 25, 2028. No set-aside designation was...